Cullinan Oncology, Inc.盘中异动股价大涨5.44%

自选股智能写手04-09

北京时间2024年04月09日21时54分，Cullinan Oncology, Inc.（CGEM.us）股票出现波动，股价急速拉升5.44%。截至发稿，该股报17.93美元/股，成交量1.9766万股，换手率0.05%，振幅4.50%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.53亿美元，每股收益-3.69美元，毛利-310000.00美元，市盈率-4.86倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2426903891?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-09 21:54","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2426903891","market":"us","top_or_hot":-1,"title":"Cullinan Oncology, Inc.盘中异动 股价大涨5.44%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月09日21时54分，Cullinan Oncology, Inc.（CGEM.us）股票出现波动，股价急速拉升5.44%。截至发稿，该股报17.93美元/股，成交量1.9766万股，换手率0.05%，振幅4.50%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.53亿美元，每股收益-3.69美元，毛利-310000.00美元，市盈率-4.86倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409215423791f6b78&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cullinan Oncology, Inc.盘中异动 股价大涨5.44%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCullinan Oncology, Inc.盘中异动 股价大涨5.44%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-09 21:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409215423791f6b78&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月09日21时54分，Cullinan Oncology, Inc.（CGEM.us）股票出现波动，股价急速拉升5.44%。截至发稿，该股报17.93美元/股，成交量1.9766万股，换手率0.05%，振幅4.50%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.53亿美元，每股收益-3.69美元，毛利-310000.00美元，市盈率-4.86倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409215423791f6b78&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409215423791f6b78&s=b","article_id":"2426903891","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409215423791f6b78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2426903891","pubTimestamp":1712670863,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月09日21时54分，Cullinan Oncology, Inc.股票出现波动，股价急速拉升5.44%。截至发稿，该股报17.93美元/股，成交量1.9766万股，换手率0.05%，振幅4.50%。Cullinan Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Acrivon Therapeutics, Inc.、Biophytis、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为366.23%、92.27%、45.29%，振幅较大的相关个股有Biophytis、Mymd Pharmaceuticals, Inc.、Acrivon Therapeutics, Inc.，振幅分别为24.30%、22.18%、20.30%。Cullinan Oncology, Inc.公司简介：Cullinan Management Inc是一家生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","CGEM":"Cullinan Therapeutics"},"translate_title":"Cullinan Oncology, Inc. shares rose 5.44% in intraday trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CGEM":1},"content_text":"北京时间2024年04月09日21时54分，Cullinan Oncology, Inc.（CGEM.us）股票出现波动，股价急速拉升5.44%。截至发稿，该股报17.93美元/股，成交量1.9766万股，换手率0.05%，振幅4.50%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.53亿美元，每股收益-3.69美元，毛利-310000.00美元，市盈率-4.86倍。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Cullinan Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Acrivon Therapeutics, Inc.、Biophytis、Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为366.23%、92.27%、45.29%，振幅较大的相关个股有Biophytis、Mymd Pharmaceuticals, Inc.、Acrivon Therapeutics, Inc.，振幅分别为24.30%、22.18%、20.30%。Cullinan Oncology, Inc.公司简介：Cullinan Management Inc是一家生物制药公司。它专注于开发针对癌症和免疫肿瘤的靶向肿瘤和免疫肿瘤疗法的多元化渠道。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2426903891"}

Cullinan Oncology, Inc.盘中异动 股价大涨5.44%

精彩评论

Cullinan Oncology, Inc.盘中异动股价大涨5.44%